Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 1437-1442, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamel, S.
Right arrow Articles by Brazier, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamel, S.
Right arrow Articles by Brazier, M.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1998;44:1437-1442.)
© 1998 American Association for Clinical Chemistry, Inc.

Enzymes and Protein Markers

Response of several markers of bone collagen degradation to calcium supplementation in postmenopausal women with low calcium intake

Saïd Kamel1,2,a, Patrice Fardellone2, Boumedienne Meddah1, Florence Lorget-Gondelmann1, Jean Luc Sebert2,2, and Michel Brazier1,2

1 Clinical Pharmacy Laboratory, Faculty of Pharmacy, 1 Rue des Louvels, 80037 Amiens, France.

2 Department of Biochemistry and of Rheumatology, Centre Hospitalier Régional d, 80054 Amiens, France.
a Author for correspondence. Fax 03-22-82-74–69; e-mail Said.Kamel{at}sa.u-picardie.fr.

We investigated the response of bone-specific resorption markers in fasting urine samples from postmenopausal women with low daily dietary calcium (Ca) intake (<800 mg/day) who received either Ca supplementation (1200 mg/day, n = 18) or placebo (n = 14) for 2 months. We measured urinary hydroxyproline, total pyridinoline, and deoxypyridinoline by HPLC, and free deoxypyridinoline (i-F-Dpd) and N- and C-telopeptide fragments of type I collagen (NTX and CTX) by immunoassays. Before supplementation, the urine concentrations of bone resorption markers in the 32 subjects were not statistically different from those measured in 21 subjects with daily dietary Ca intake >800 mg/day. In contrast to the placebo group, Ca supplementation decreased all collagen-related degradation markers except i-F-Dpd as early as the first month. The magnitude of response after 2 months of Ca supplementation, expressed as mean percentage of decrease from baseline values or as individual Z scores, was greatest for the telopeptide assays. Furthermore, the percentage of change assessed at 2 months was greater than the within-person biological variability (CV) assessed in the placebo-treated women for NTX and CTX, whereas for the other markers the percentage of change was very close of the within-person CVs. We conclude that cross-linked telopeptide fragments of type I collagen most sensitively reflect the change in bone resorption after Ca supplementation.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
R. L. Fitzgerald, D. J. Hillegonds, D. W. Burton, T. L. Griffin, S. Mullaney, J. S. Vogel, L. J. Deftos, and D. A. Herold
41Ca and Accelerator Mass Spectrometry to Monitor Calcium Metabolism in End Stage Renal Disease Patients
Clin. Chem., November 1, 2005; 51(11): 2095 - 2102.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
P.-H. Lin, F. Ginty, L. J. Appel, M. Aickin, A. Bohannon, P. Garnero, D. Barclay, and L. P. Svetkey
The DASH Diet and Sodium Reduction Improve Markers of Bone Turnover and Calcium Metabolism in Adults
J. Nutr., October 1, 2003; 133(10): 3130 - 3136.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J. Guillemant, H.-T. Le, C. Accarie, S. T. du Montcel, A.-M. Delabroise, M. J Arnaud, and S. Guillemant
Mineral water as a source of dietary calcium: acute effects on parathyroid function and bone resorption in young men
Am. J. Clinical Nutrition, April 1, 2000; 71(4): 999 - 1002.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. C. Kress, I. A. Mizrahi, K. W. Armour, R. Marcus, R. D. Emkey, and A. C. Santora II
Use of Bone Alkaline Phosphatase to Monitor Alendronate Therapy in Individual Postmenopausal Osteoporotic Women
Clin. Chem., July 1, 1999; 45(7): 1009 - 1017.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.